Analyst Michelle Gilson works at CANACCORD and is covering the the Healthcare sector with 104 price targets and ratings documented since 2016 spanning on 11 stocks. Previously, Michelle Gilson worked at OPPENHEIMER.
Michelle Gilson's average stock forecast success ratio is 38.75% with an average time for price targets to be met of 142.5 days.
Most recent stock forecast was given on SGTX, Sigilon Therapeutics Inc at 28-Dec-2021.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS, INC).
The best stock recommendation documented was for CCXI (CHEMOCENTRYX, INC) at 5/19/2020. The price target of $58 was fulfilled within 1 day with a profit of $1.98 (3.53%) receiving and performance score of 35.34.
Average potential price target upside
Currently, out of the existing stock ratings of Michelle Gilson - 6 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
186
$96.25 (107.24%)
164
22 days ago
1/6 (16.67%)
$48.91 (44.67%)
13
Buy
146
$56.25 (62.67%)
163
1 months 25 days ago
3/15 (20%)
$56.67 (54.38%)
138
Buy
144
1 months 25 days ago
0/7 (0%)
$67.45 (59.34%)
Buy
108
$18.25 (20.33%)
151
1 months 26 days ago
2/14 (14.29%)
$46.77 (39.85%)
88
Buy
92
$2.25 (2.51%)
161
1 months 26 days ago
3/5 (60%)
$19.89 (23.27%)
55
